Dear Anon,
With respect to Canada, see Section 2 (exemptions) of GUI-002 (Guidance on Drug Establishment Licenses). The guide notes that 'activities that comply with an authorised clinical trial do not require a DEL, except for clinical trials involving a marketed product used according to its Health Canada market authorization, sometimes referred to as a Phase IV clinical trial'. I hope this helps.
Kind regards,
Felicia
------------------------------
Felicia Mohammed RAC
Regulatory Affairs Manager
North York ON
Canada
------------------------------
Original Message:
Sent: 23-Dec-2020 08:19
From: Anonymous Member
Subject: Establishment License
This message was posted by a user wishing to remain anonymous
Dear RAPS members,
Should the DS and/ or DP manufacturer (CMO) look for Establishment license (EL) even if they manufacture clinical trial material and not commercial doses? Is there any applicable certification for such a facility?
My understanding is EL is required only for commercial manufacturing.
Thank you for sharing your experience.